COVID-19 Vaccines in the Pediatric Population: A Focus on Cardiac Patients
- PMID: 38779616
- PMCID: PMC11111306
- DOI: 10.1155/2024/2667033
COVID-19 Vaccines in the Pediatric Population: A Focus on Cardiac Patients
Abstract
Due to the deleterious global impact of the COVID-19 pandemic, tremendous effort has been invested in the development of vaccines against the virus. Vaccine candidates are first tested in adult populations, a number of which have been approved for EUL by the WHO, and are in use across the USA and MENA region. The question remains whether these (or other) vaccines should be recommended to a neonatal, pediatric, and/or adolescent cohort. Incidence and severity of COVID-19 infection are low in pediatric, neonatal, and adolescent patients. Since both overall incidence and severity are lower in children than in adults, safety is an important consideration in vaccine approval for these age groups, in addition to efficacy and a decreased risk of transmission. The following review discusses vaccine immunology in children aged 0-18 years, with emphasis on the negative impact of the COVID-19 pandemic on the lives of children, considerations for pediatric vaccine approval, and available vaccines for pediatric cohorts along with a breakdown of the efficacy, advantages, and disadvantages for each. This review also contains current and future perspectives, as well as a section on the cardiovascular implications and related dynamics of pediatric COVID-19 vaccination.
Copyright © 2024 Ghena Lababidi et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
COVID-19 Vaccination in Children: An Open Question.Curr Pediatr Rev. 2022;18(3):226-236. doi: 10.2174/1573396318666211220093111. Curr Pediatr Rev. 2022. PMID: 34931965 Review.
-
Is there a role for childhood vaccination against COVID-19?Pediatr Allergy Immunol. 2021 Jan;32(1):9-16. doi: 10.1111/pai.13401. Epub 2020 Nov 20. Pediatr Allergy Immunol. 2021. PMID: 33113210 Review.
-
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Oct 10;43(10):1515-1544. doi: 10.3760/cma.j.cn112338-20220825-00734. Zhonghua Liu Xing Bing Xue Za Zhi. 2022. PMID: 36456484 Chinese.
-
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 36274602 Chinese.
-
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1. Trials. 2021. PMID: 33849629 Free PMC article.
References
-
- Roberton T., Carter E. D., Chou V. B., et al. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Lancet Global Health . 2020;8(7):e901–e908. doi: 10.1016/s2214-109x(20)30229-1. - DOI - PMC - PubMed
-
- Falk G., Romero P. D., Nicchitta I. A., Nyhof E. C. Unemployment rates during the COVID-19 pandemic- congress. Unemployment Rates During the COVID-19 Pandemic . 2021 https://crsreports.congress.gov/product/pdf/R/R46554/9 .
-
- Contini D., Di Tommaso M. L., Muratori C., Piazzalunga D., Schiavon L. The COVID-19 pandemic and school closure: learning loss in mathematics in primary education. SSRN Electronic Journal . 2021 doi: 10.2139/ssrn.4114323. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Research Materials